AdvanSix’s Rising Sales Mask Weaker Earnings as Ammonia Expansion Advances

AdvanSix increased third-quarter sales by 15%, but higher input costs and reduced production pushed earnings lower. The company, which makes nylon materials, fertilizers and industrial chemicals, reported adjusted EBITDA of $14.6 million, down from $24.7 million a year earlier. Its GAAP net loss widened to $7.6 million.

Cash flow improved in the quarter, helped by inventory and payable movements. At the same time, AdvanSix has been selected for proposed federal funding toward a multiyear ammonia expansion. The grant could reduce the company’s share of the project’s cost, but stronger operating cash generation remains important as it maintains its existing plants and invests in additional capacity.

One production network, several markets

AdvanSix operates an integrated manufacturing network that makes several products from connected chemical processes. It produces caprolactam, a building block for nylon 6, and converts some of that output into nylon resin used in products such as packaging, automotive components and industrial materials.

The company also sells ammonium sulfate, a fertilizer supplying nitrogen and sulfur, and chemical intermediates including acetone. Some ammonium sulfate is produced alongside caprolactam; the company is also expanding its ability to make fertilizer directly. This connection gives management choices about how to use ammonia and other inputs, but demand and pricing can differ across its end markets.

In the third quarter, plant nutrients accounted for $149.3 million, or 35%, of company sales. Nylon contributed $104.7 million, caprolactam $73.1 million and chemical intermediates $103.7 million. Those figures describe product-line sales. AdvanSix does not disclose separate profit for each line, so the consolidated earnings figures cannot show which line generated the most profit.

Higher prices did not restore margins

Third-quarter revenue rose to $430.8 million from $374.5 million. Management attributed the increase to a 17% pricing benefit, partly offset by a 2% decline in volume. Its price analysis included a 10% contribution from raw-material pass-through arrangements and 7% from market-based pricing. Lower caprolactam sales drove much of the volume decline.

Source: AdvanSix third-quarter results. Gross profit is calculated as sales less cost of goods sold.

Higher sales included amounts passed through to cover more expensive inputs. Management said raw materials were a $65 million year-over-year headwind to adjusted EBITDA, led by sulfur and benzene. Pricing in nylon and chemical intermediates more than offset the effect of higher benzene and propylene costs in those product lines, management said. Plant nutrients faced a less favorable balance between fertilizer pricing and sulfur costs.

Reduced production added pressure because fixed factory costs were spread across less output. Management also reported cost savings, including benefits within selling, general and administrative expenses. Consolidated gross profit nevertheless fell to $11.2 million from $25.4 million.

The GAAP net loss increased even though selling, general and administrative expense fell to $19.2 million from $27.4 million. Net interest expense rose to $4.0 million from $2.3 million. Adjusted EBITDA adds back interest, tax and depreciation and includes other adjustments; it is not cash earnings after maintaining the plants. For the quarter, the company reconciled its $7.6 million GAAP loss to a $6.6 million adjusted net loss, mainly by adding back stock compensation and acquisition-related amortization, net of tax.

A stronger quarter for cash

Operating cash flow rose to $48.0 million from $26.6 million in the prior-year quarter, despite the wider net loss. A $44.3 million increase in accounts payable and a $12.7 million reduction in inventory supported cash flow. Receivables used $6.2 million, while accrued liabilities used $12.1 million. Depreciation and amortization added back $21.1 million because it reduced accounting earnings without an equivalent current-period cash charge.

Capital expenditure declined to $18.3 million from $26.5 million. AdvanSix therefore reported $29.7 million of free cash flow, which it defines as operating cash flow less capital expenditure, compared with approximately $0.1 million a year earlier.

The company’s cash-flow statement shows a weaker nine-month picture. Operating cash flow was $42.7 million and capital spending was $74.9 million, leaving free cash flow of negative $32.3 million. Inventory released $55.1 million during the period, while receivables absorbed $39.6 million and customer advances declined by $12.9 million.

Management sees a path to approximately break-even free cash flow for 2026. Given the nine-month deficit, that implies roughly $32.3 million of positive free cash flow in the fourth quarter. With about $15.1 million of capital spending implied by the $90 million annual forecast, operating cash flow would need to be about $47.3 million. These are calculations from the company’s figures, not a separate company forecast.

A fertilizer pre-buy program, under which customers pay ahead of the next growing season, is part of that expectation. Such advances can improve cash flow when received, while the associated product must still be supplied later. Management’s break-even path excludes an expected $18 million carbon-capture tax refund for 2018–2020; it said the refund could move into 2027 and had not yet received formal notification.

Debt and planned investment

At September 30, AdvanSix had $22.6 million in cash. Its credit agreement comprised a $150 million term facility and a $275 million revolving facility. The company reported $270 million in borrowings before debt issuance-cost adjustments and approximately $154 million of available credit. These are drawn and available amounts, not separate cash balances.

Nine-month financing cash flow was positive $35.6 million. It included $150 million of term-loan proceeds and $95 million of net revolving-credit repayments, alongside financing fees and $12.9 million of dividend payments. Together with $42.7 million of operating inflow and $75.5 million of investing outflow, those movements explain the $2.8 million increase in cash during the period.

The new facilities mature in August 2031, according to the quarterly filing. The agreement includes leverage and interest-coverage covenants, and the company said it was in compliance at September 30 and through its quarterly filing date. Actual future borrowing capacity will depend on those terms and operating performance.

For 2026, management now expects about $90 million of capital spending, within its previous $75 million–$95 million range. That annual figure includes spending on existing growth programs such as SUSTAIN; it should not be added again to the same projects’ annual costs.

Ammonia expansion comes with conditions

On October 29, AdvanSix said it had been selected for $47.4 million of proposed U.S. Department of Agriculture funding for Project CENTURY at its Hopewell, Virginia, site. The planned $98.1 million multiyear project would modernize the ammonia facility and add approximately 84,000 tons of annual ammonia production capacity.

The proposed federal amount equals about 48.3% of the stated project cost, leaving approximately $50.7 million before any other funding or changes in scope. The grant has not yet been received: it remains subject to USDA administrative and risk reviews. Management expects the investment to run through 2031, with modest 2027 spending and more concentrated spending in 2029–2031.

Additional ammonia could be sold or used within the company’s integrated operations, including fertilizer production. Management expects the proposed grant structure to support a project return above its 20% discretionary-investment hurdle, but the company has not disclosed the underlying cash-flow assumptions.

Some modernization work would otherwise be considered within ongoing capital spending. Management’s preliminary starting point for 2027 is approximately $80 million for base capital and the final SUSTAIN project, with a fuller view of incremental discretionary spending to follow. The $98.1 million project total should therefore not be mechanically added to every annual capital plan.

The near-term measure is whether AdvanSix can generate the roughly $47 million of fourth-quarter operating cash implied by its break-even free-cash-flow path while managing customer advances and planned investment. Beyond that, the company’s ability to improve the spread between fertilizer prices and sulfur costs, alongside the final grant terms, will influence how much cash is available for expansion.